openPR Logo
Press release

Quick Heal wins its 35th VB100% award

02-21-2011 12:49 PM CET | IT, New Media & Software

Press release from: Quick Heal Technologies (P) Ltd

Pune, February 06, 2011

Quick Heal Technologies (P) Ltd. is proud to inform that Quick Heal has received Virus Bulletin's acclaimed VB100% award for successfully detecting all the viruses "In-The-Wild" during comparative testing of AntiVirus products. This is the 35th VB100% award secured by Quick Heal and the 6th on Linux platform.

This test was conducted on Ubuntu Linux Server Edition 10.04.1 LTS i386 and its review is published in February 2011 issue of Virus Bulletin magazine, UK.
"Day by day, there is a rapid change in the security landscape. There is an increase in number and complexity of malwares daily. In spite of that Quick Heal strives hard to protect its customers from the deadliest and ever increasing number of malwares. The achievement of Quick Heal in such stringent test is the result of dedicated and sincere efforts by the entire Quick Heal team and the encouragement given by our customers and well wishers. The consistency in the quality of the products and services has increased the faith of our users in our company. We will take all measures to maintain this faith" says Sanjay Katkar, CTO, Quick Heal Technologies (P) Ltd.
Quick Heal is the only Indian AntiVirus achieving this award 35 times on various Operating Systems.
For more information on Quick Heal Technologies, visit www.quickheal.com.

Quick Heal best internet security software, now track your stolen laptop with laptop tracking software, best virus protection antispam software, top antivirus software 2011.

603 Mayfair Towers II, Wakdewadi,Shivajinagar, 411005
Pune, Maharashtra, India.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Quick Heal wins its 35th VB100% award here

News-ID: 163340 • Views: 2017

More Releases from Quick Heal Technologies (P) Ltd

Quick Heal Voted as the Most Preferred Channel Brand for the Third Consecutive Y …
Wins #1 Title in Consumer and SOHO Antivirus (AV) Category - According to a Leading Survey Pune, March 17, 2011 Quick Heal Technologies retained its number one title in Consumer and SOHO Antivirus (AV) Category for the third consecutive year. The CRN Magazine survey for CRN Channel Champions 2010, which is conducted in more than 147 cities, has revealed that Quick Heal is the most widely distributed and preferred Antivirus. It maintains
Award-winning Quick Heal Devises Global Expansion Plan
Pune, February 25, 2011 Quick Heal Technologies, the leading provider of Internet Security tools, continues to expand its global operations through distributors and channel partners. The company has recently signed up with five partners in Italy, Kenya, Bangladesh and Syria as part of its global expansion initiatives. With these partnerships, Network SAS Di A.Bettoni from Italy, Smart Technologies bd Ltd. from Bangladesh, MIS Software Nigeria Limited from Nigeria, Plus X Company
Award-winning Quick Heal Launches 2011 Series
Pune, December 16, 2010 Quick Heal Technologies has unveiled the brand new 2011 series of its computer security solution. The new release promises to provide the best user interface and ease of use to the users – while providing a very robust solution for blocking viruses, spywares, roguewares and other malwares. Apart from this, the new release also includes unique features like Parental Control and Web Security. The enhancements and improvements

All 4 Releases


More Releases for Virus

major breakthrough in corona virus protection
The worlds first face mask tested and Certified in the EU to inactivate Corona Virus Covid19 Wear with confidence of not picking up the virus or passing it on THE WORLDS FIRST FACEMASK TESTED AND PROVEN TO INACTIVATE COVID19 FFP2 Level 2 Professional use Tests carried out by the Instituto de Medicina Molecular on the face mask attest to its capacity to inactivate the new coronavirus, SARS-CoV-2, which causes COVID-19. This joint project has
Viral Disease Diagnosis Market to See Huge Growth by 2025 | Measles Virus, Polio …
Global Viral Disease Diagnosis Market: Snapshot Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.
Virus Free Corporate Training
Interaction for learning is critical but our customers are slowly starting to realise that this doesn’t necessarily need to take place face to face. Virtual instructor led training (VILT) makes learning more accessible by removing geographical barriers. It helps improve user product adoption, knowledge and career development and eliminates the need for costly and time-consuming travel. Still, there’s often a misconception that in person training is the only type of
Nanoscale Virus Trap Molecule Market
Advancement into scientific research has led to the emergence of new technologies that has the potential to improve drug delivery and effectiveness. With evolution, things are becoming miniature in size, be it electronic chips, medical devices, or pharmaceutical drug. However, miniaturization, also referred as nanotechnology, doesn’t compromise on the product quality and effectiveness. Instead there is improved quality and features delivered via this technology. Nanotechnology has a real potential to revolutionize
Global Oncolytic Virus Therapy Pipeline Analysis
Though still in nascent stages, Oncolytic viruses have shown immense opportunities and potential to be tapped in the future to improve the treatment of cancer and the lives of the patients. Immunotherapy, the umbrella for Oncolytic viruses would not offer cures, but survival solutions with significant importance. Also, the side effects of this therapy would be tolerable by the patients, which could thus become the most important approach to treat
Ebola Virus Vaccine Market & Pipeline Insight
Ebola virus infection, which was previously called Ebola hemorrhagic fever was discovered in 1976. The infection caused due to ebola virus originates from four different strains of ebola virus. These viruses generally are known to affect non-human primates, and are transmitted from wild animals to the humans and among the latter, it is known to spread through human-to-human transmission. The natural hosts of ebola virus are Fruit bats, which